norocillin 300 mg/ml suspensija injekcijām
norbrook laboratories (ireland) limited, Īrija - benzilpenicilīna prokaīna sāls - suspensija injekcijām - 300 mg/ml - aitas; cūkas; liellopi
multimast dry cow suspensija ievadīšanai tesmenī
bimeda animal health limited, Īrija - neomycin sulphate, procaine benzylpenicillin, penethamate hydroiodide - suspensija ievadīšanai tesmenī - cietstāvošas govis
intramicine suspensija injekcijām
ceva sante animale., francija - dihydrostreptomycin sulphate, procaine benzylpenicillin - suspensija injekcijām - aitas; cūkas; govis; kazas; kaķi; suņi; zirgi
multiject imm suspensija ievadīšanai tesmenī
norbrook laboratories (ireland) limited, Īrija - neomycin sulphate, streptomycin sulphate, procaine benzylpenicillin, prednisolone - suspensija ievadīšanai tesmenī - govis
nafpenzal dc suspensija ievadīšanai tesmenī
intervet international b.v., nīderlande - procaine benzylpenicillin, nafcillin, dihydrostreptomycin sulphate - suspensija ievadīšanai tesmenī - liellopi
ferrola 114 mg/0,8 mg modificētās darbības tabletes
wörwag pharma gmbh & co.kg, germany - ferrosi sulfas desiccatus, acid-folicum - modificētās darbības tablete - 114 mg/0,8 mg
tardyliq 20 mg/ml šķīdums iekšķīgai lietošanai
pierre fabre medicament, france - dzelzs - Šķīdums iekšķīgai lietošanai - 20 mg/ml
jayempi
nova laboratories ireland limited - azatioprīns - transplanta noraidīšana - imūnsupresanti - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.
tardyferon 80 mg ilgstošās darbības tabletes
pierre fabre medicament, france - dzelzs - ilgstošās darbības tablete - 80 mg
wilzin
recordati rare diseases - cinks - hepatolenticulāra deģenerācija - citas gremošanas trakta un metabolisma produkti, - vilsona slimības ārstēšana.